This proposal is a competing renewal for the Penn Center for AIDS Research (CFAR), which includes the University of Pennsylvania, The Children's Hospital of Philadelphia, and The Wistar Institute. The Penn CFAR links HIV/AIDS investigators at these institutions and is committed to goals laid out in the NIH CFAR mission statement and fostering interdisciplinary HIV/AIDS research activities on the Penn/CHOP/Wistar campus. The CFAR's Specific Aims are to: (1) provide leadership that creates and supports infrastructure for innovative, interdisciplinary, collaborative, and translational HIV/AIDS research: (2) identify new areas of scientific opportunity in HIV/AIDS research;(3) create, sponsor and facilitate educational and training programs across diverse scientific areas and play a leadership role in mentoring the next generation of HIV/AIDS investigators;(4) conduct and coordinate community outreach efforts: (5) promote collaborative and synergistic activities and research programs between CFARs that extend the added value of individual CFARs;and (6) develop partnerships with institutions and investigators outside the U.S. that strengthen capacity for HIV/AIDS research and mentoring in developing countries and resource limited settings most affected by the AIDS pandemic. The Penn CFAR includes four Research Areas: Virology/ Pathogenesis, Clinical/Therapeutics, Immunology/Vaccine, and Behavioral &Social Sciences, and has created three forward-looking and dynamic Scientific Working Groups to meet key emerging scientific priorities and opportunities in HIV/AIDS research. The Center is directed by Dr. James Hoxie, co-directed by Dr. Ronald Collman and governed by an Executive Committee with input from an Internal Advisory Board and External Advisory Committee. The CFAR has a Developmental Core and seven Shared Resource Cores: Clinical, Viral/Molecular, Immunology, Behavioral &Social Sciences, Biostatistics &Data Management. Nonhuman Primate, and International. These Cores provide unique services for HIV/AIDS research that are not available elsewhere on campus, leadership and education. The Center remains committed to developing a creative, comprehensive, and interdisciplinary AIDS research program that is fully integrated with the research and educational missions of Penn, CHOP and Wistar and dedicated to meeting the ongoing challenges of the AIDS pandemic.

Public Health Relevance

This CFAR will build on the success and strengths of its three previous funding cycles to 1) provide strong, experienced, and proactive leadership;2) contribute to a rich environment of interdisciplinary HIV/AIDS science;3) develop and lead new initiatives in cutting-edge areas that address the NIH Strategic Plan for HIV research;and 4) foster collegial and collaborative relationships among its investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI045008-16
Application #
8682232
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Namkung, Ann S
Project Start
1999-07-01
Project End
2019-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
16
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Krump, Nathan A; Liu, Wei; You, Jianxin (2018) Mechanisms of persistence by small DNA tumor viruses. Curr Opin Virol 32:71-79
Gowda, Charitha; Lott, Stephen; Grigorian, Matthew et al. (2018) Absolute Insurer Denial of Direct-Acting Antiviral Therapy for Hepatitis C: A National Specialty Pharmacy Cohort Study. Open Forum Infect Dis 5:ofy076
Clarke, Erik L; Connell, A Jesse; Six, Emmanuelle et al. (2018) T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. Genome Med 10:70
Coviello, D M; Lovato, R; Apostol, K et al. (2018) Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders. Community Ment Health J :
Martei, Yehoda M; Pace, Lydia E; Brock, Jane E et al. (2018) Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge. Clin Lab Med 38:161-173
Ojikutu, Bisola O; Bogart, Laura M; Higgins-Biddle, Molly et al. (2018) Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav 22:3576-3587
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Wood, Sarah; Ratcliffe, Sarah; Gowda, Charitha et al. (2018) Impact of insurance coverage on HIV transmission potential among antiretroviral therapy-treated youth living with HIV. AIDS 32:895-902
Shin, S S; Modongo, C; Zetola, N M et al. (2018) High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana. Int J Tuberc Lung Dis 22:366-370
Genn, Leah; Chapman, Jennifer; Okatch, Harriet et al. (2018) Pharmacy Refill Data are Poor Predictors of Virologic Treatment Outcomes in Adolescents with HIV in Botswana. AIDS Behav :

Showing the most recent 10 out of 775 publications